Jazz Pharmaceuticals

$141.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$1.00 (-0.70%) Today
$0.00 (0.00%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell JAZZ and other stocks, options, and ETFs commission-free!

About JAZZ

Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland. The listed name for JAZZ is Jazz Pharmaceuticals plc Common Stock (Ireland).

CEO
Bruce C. Cozadd
Employees
1,620
Headquarters
Dublin, Dublin
Founded
2003
Market Cap
7.90B
Price-Earnings Ratio
45.63
Dividend Yield
Average Volume
562.07K
High Today
$144.00
Low Today
$141.03
Open Price
$142.38
Volume
361.26K
52 Week High
$158.98
52 Week Low
$86.88

Collections

JAZZ Earnings

$0.00
$1.47
$2.95
$4.42
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Feb 23, After Hours

You May Also Like